4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide
C23H17Cl2F3N2O3 — CID 91213501
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide (PubChem CID 91213501) has the molecular formula C23H17Cl2F3N2O3 and a molecular weight of 497.30 g/mol. Its IUPAC name is 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide.
Molecular Properties
| Compound Name | 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide |
|---|---|
| PubChem CID | 91213501 |
| Molecular Formula | C23H17Cl2F3N2O3 |
| Molecular Weight | 497.30 g/mol |
| Exact Mass | 496.06 |
| IUPAC Name | 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-2H-1,2-oxazol-3-yl]-N-(2-hydroxyethyl)naphthalene-1-carboxamide |
| SMILES | O=C(NCCO)c1ccc(C2=CC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)ON2)c2ccccc12 |
| InChI | InChI=1S/C23H17Cl2F3N2O3/c24-14-9-13(10-15(25)11-14)22(23(26,27)28)12-20(30-33-22)18-5-6-19(21(32)29-7-8-31)17-4-2-1-3-16(17)18/h1-6,9-12,30-31H,7-8H2,(H,29,32) |
| InChIKey | QRQRHGSZHGIHAH-UHFFFAOYSA-N |
| XLogP | 5.20 |
| TPSA | 70.59 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.30 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91213501 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.